Cargando…
The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China
BACKGROUND: Since 2015, China has been rolling out the pricing reform for drugs and medical services (PRDMS) in the urban public hospitals in order to reduce drug expenditures and to relieve financial burdens of patients. This study aims at evaluating the effectiveness of the reform and investigatin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682084/ https://www.ncbi.nlm.nih.gov/pubmed/33225941 http://dx.doi.org/10.1186/s12913-020-05849-4 |
_version_ | 1783612638826070016 |
---|---|
author | Zhang, Xiaoxi Lai, Hongyu Zhang, Lidan He, Jiangjiang Fu, Bo Jin, Chunlin |
author_facet | Zhang, Xiaoxi Lai, Hongyu Zhang, Lidan He, Jiangjiang Fu, Bo Jin, Chunlin |
author_sort | Zhang, Xiaoxi |
collection | PubMed |
description | BACKGROUND: Since 2015, China has been rolling out the pricing reform for drugs and medical services (PRDMS) in the urban public hospitals in order to reduce drug expenditures and to relieve financial burdens of patients. This study aims at evaluating the effectiveness of the reform and investigating its positive impacts and unintended consequences to provide evidence basis for further policy making. METHODS: The Difference-in-difference (DID) approach was employed to analyze the reform impacts on the 31 provincial administrative areas in China based on data abstracted from China Statistics Yearbooks and China Health Statistics Yearbooks from 2012 to 2018. RESULTS: The reform resulted in a decrease of 7.59% in drug cost per outpatient visit, a decrease of 5.73% in drug cost per inpatient admission, a decrease of 3.63% in total cost per outpatient visit and an increase of 9.10% in surgery cost per inpatient admission in the intervention group. However, no significant change in examination cost was found. The reduction in the medical cost per inpatient admission was not yet demonstrated, nor was that in the total outpatient/ inpatient expenses. The nationwide pricing reform for drugs and medical services in urban public hospitals (PRDMS-U) in China is demonstrated to be effective in cutting down the drug expenditures. However, the revealed unintended consequences indicate that there are still significant challenges for the reform to reach its ultimate goal of curbing the medical expenditures. CONCLUSION: We conclude that the pricing reform alone may not be enough to change the profit-driven behavior of medical service providers as the root cause lies in the unchanged incentive scheme for providers in the service delivery. This holds lessons for policy making of other low- and middle-income countries (LMICs) with similar health systems set up in the achievement of Universal Health Coverage (UHC). |
format | Online Article Text |
id | pubmed-7682084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76820842020-11-23 The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China Zhang, Xiaoxi Lai, Hongyu Zhang, Lidan He, Jiangjiang Fu, Bo Jin, Chunlin BMC Health Serv Res Research Article BACKGROUND: Since 2015, China has been rolling out the pricing reform for drugs and medical services (PRDMS) in the urban public hospitals in order to reduce drug expenditures and to relieve financial burdens of patients. This study aims at evaluating the effectiveness of the reform and investigating its positive impacts and unintended consequences to provide evidence basis for further policy making. METHODS: The Difference-in-difference (DID) approach was employed to analyze the reform impacts on the 31 provincial administrative areas in China based on data abstracted from China Statistics Yearbooks and China Health Statistics Yearbooks from 2012 to 2018. RESULTS: The reform resulted in a decrease of 7.59% in drug cost per outpatient visit, a decrease of 5.73% in drug cost per inpatient admission, a decrease of 3.63% in total cost per outpatient visit and an increase of 9.10% in surgery cost per inpatient admission in the intervention group. However, no significant change in examination cost was found. The reduction in the medical cost per inpatient admission was not yet demonstrated, nor was that in the total outpatient/ inpatient expenses. The nationwide pricing reform for drugs and medical services in urban public hospitals (PRDMS-U) in China is demonstrated to be effective in cutting down the drug expenditures. However, the revealed unintended consequences indicate that there are still significant challenges for the reform to reach its ultimate goal of curbing the medical expenditures. CONCLUSION: We conclude that the pricing reform alone may not be enough to change the profit-driven behavior of medical service providers as the root cause lies in the unchanged incentive scheme for providers in the service delivery. This holds lessons for policy making of other low- and middle-income countries (LMICs) with similar health systems set up in the achievement of Universal Health Coverage (UHC). BioMed Central 2020-11-23 /pmc/articles/PMC7682084/ /pubmed/33225941 http://dx.doi.org/10.1186/s12913-020-05849-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Zhang, Xiaoxi Lai, Hongyu Zhang, Lidan He, Jiangjiang Fu, Bo Jin, Chunlin The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China |
title | The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China |
title_full | The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China |
title_fullStr | The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China |
title_full_unstemmed | The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China |
title_short | The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China |
title_sort | impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in china |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682084/ https://www.ncbi.nlm.nih.gov/pubmed/33225941 http://dx.doi.org/10.1186/s12913-020-05849-4 |
work_keys_str_mv | AT zhangxiaoxi theimpactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT laihongyu theimpactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT zhanglidan theimpactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT hejiangjiang theimpactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT fubo theimpactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT jinchunlin theimpactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT zhangxiaoxi impactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT laihongyu impactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT zhanglidan impactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT hejiangjiang impactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT fubo impactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina AT jinchunlin impactsandunintendedconsequencesofthenationwidepricingreformfordrugsandmedicalservicesintheurbanpublichospitalsinchina |